InfuSystem Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Leases (Tables)

12 Months Ended

Dec. 31, 2022

The components of the Company’s operating lease costs consisted of the following (in thousands):

Supplemental cash flow information and non-cash activity related to the Company’s leases are as follows (in thousands):


	Years Ended December 31,
	2022		2021		2020
Cash paid for amounts included in the measurement of lease liabilities and right of use assets:
Operating cash flow from operating leases	$	1,241	$	1,271	$	1,603

Right of use assets obtained in exchange for lease obligations:
Operating leases	$	18	$	926	$	264



Increases to right of use assets resulting from lease modifications:
Operating leases	$	1,050	$	—	$	—

Weighted average remaining lease terms and discount rates for the Company’s operating leases are as follows:


	2022	2021
	Years	Years
Weighted average remaining lease term:	6.7	6.3
	Rate	Rate
Weighted average discount rate:	7.1%	7.5%

Future maturities of lease liabilities as of December 31, 2022 are as follows (in thousands):


	Operating Leases (a)
2023	$	1,159
2024	1,064
2025	1,033
2026	998
2027	826
Thereafter	2,016
Total undiscounted lease payments	7,096
Less: Imputed interest	(2,404)
Total lease liabilities	$	4,692

(a) Excludes $1.8 million of legally binding minimum lease payments for an office lease signed but not yet commenced. This lease has an expected term of 7 years and is expected to commence in 2023.